Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
570
-
Total 13F shares, excl. options
-
98.3M
-
Shares change
-
+830K
-
Total reported value, excl. options
-
$14.5B
-
Value change
-
+$119M
-
Put/Call ratio
-
1.01
-
Number of buys
-
273
-
Number of sells
-
-268
-
Price
-
$147.29
Significant Holders of RESMED INC - Common Stock (RMD) as of Q1 2020
667 filings reported holding RMD - RESMED INC - Common Stock as of Q1 2020.
RESMED INC - Common Stock (RMD) has 570 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98.3M shares
of 146M outstanding shares and own 67.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (16.1M shares), BlackRock Inc. (12.3M shares), WCM INVESTMENT MANAGEMENT, LLC (8.17M shares), STATE STREET CORP (6.66M shares), FMR LLC (5.71M shares), Capital World Investors (5.54M shares), BAILLIE GIFFORD & CO (4.53M shares), GEODE CAPITAL MANAGEMENT, LLC (2.46M shares), Invesco Ltd. (2.45M shares), and NORTHERN TRUST CORP (2.05M shares).
This table shows the top 570 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.